These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26063717)

  • 1. Editorial Commentary: Fosfomycin: The Current Status of the Drug.
    Falagas ME; Rafailidis PI
    Clin Infect Dis; 2015 Oct; 61(7):1144-6. PubMed ID: 26063717
    [No Abstract]   [Full Text] [Related]  

  • 2. Fosfomycin for Treatment of Prostatitis: New Tricks for Old Dogs.
    Grayson ML; Macesic N; Trevillyan J; Ellis AG; Zeglinski PT; Hewitt NH; Gardiner BJ; Frauman AG
    Clin Infect Dis; 2015 Oct; 61(7):1141-3. PubMed ID: 26063723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Fosfomycin and Prostatitis.
    Davido B; Dinh A
    Clin Infect Dis; 2016 Mar; 62(5):671-2. PubMed ID: 26689959
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Davido and Dinh.
    Grayson ML; Macesic N; Trevillyan J
    Clin Infect Dis; 2016 Mar; 62(5):672. PubMed ID: 26689958
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fosfomycin for urogenital tract infections: Advances in studies].
    Mo DS; Liu W; Shang XJ; Zheng DD
    Zhonghua Nan Ke Xue; 2015 May; 21(5):467-71. PubMed ID: 26117948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged course of Fosfomycin-Trometamol for chronic prostatitis: an unknown good option.
    Denes E
    Scand J Urol; 2021 Aug; 55(4):344-345. PubMed ID: 34060413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study.
    Demonchy E; Courjon J; Ughetto E; Durand M; Risso K; Garraffo R; Roger PM
    Int J Antimicrob Agents; 2018 Jun; 51(6):836-841. PubMed ID: 29378342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities.
    Fedrigo NH; Mazucheli J; Albiero J; Shinohara DR; Lodi FG; Machado ACDS; Sy SKB; Tognim MCB
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis.
    Los-Arcos I; Pigrau C; Rodríguez-Pardo D; Fernández-Hidalgo N; Andreu A; Larrosa N; Almirante B
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1854-8. PubMed ID: 26666924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raoultella planticola chronic bacterial prostatitis with prostatic calcifications: successful treatment with prolonged fosfomycin therapy.
    Gian J; Cunha BA
    Int J Antimicrob Agents; 2016 May; 47(5):414. PubMed ID: 27085452
    [No Abstract]   [Full Text] [Related]  

  • 11. Fosfomycin for bacterial prostatitis: a review.
    Kwan ACF; Beahm NP
    Int J Antimicrob Agents; 2020 Oct; 56(4):106106. PubMed ID: 32721595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
    Aris P; Boroumand MA; Rahbar M; Douraghi M
    Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fosfomycin for urinary tract infections.
    Med Lett Drugs Ther; 1997 Jul; 39(1005):66-8. PubMed ID: 9255237
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of fosfomycin in the management of urinary tract infections].
    Zaitsev AV; Kolontarev KB
    Urologiia; 2017 Sep; (4):91-96. PubMed ID: 28952700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Our experience in the use of fosfomycin in human therapy].
    De Rosa F; Pauselli A; Matocci G; Petrucci G
    Minerva Med; 1978 Dec; 69(59):4115-8. PubMed ID: 105328
    [No Abstract]   [Full Text] [Related]  

  • 16. Multidrug-resistant Gram-negative bacilli causing urinary tract infections: clinical considerations.
    Cunha BA
    J Chemother; 2011 Jun; 23(3):171-4. PubMed ID: 21742588
    [No Abstract]   [Full Text] [Related]  

  • 17. Fosfomycin: A Revisited Antibiotic for Urinary Tract Infections.
    Parikh FS
    J Assoc Physicians India; 2017 Sep; 65(9):11. PubMed ID: 29313569
    [No Abstract]   [Full Text] [Related]  

  • 18. Fosfomycin in chronic urinary infections.
    Allona A; Díaz Cabrera JA; Manchado P
    Chemotherapy; 1977; 23 Suppl 1():267-74. PubMed ID: 851501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent extended-spectrum β-lactamase-positive Escherichia coli chronic prostatitis successfully treated with a combination of fosfomycin and doxycycline.
    Cunha BA; Gran A; Raza M
    Int J Antimicrob Agents; 2015 Apr; 45(4):427-9. PubMed ID: 25662814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fosfomycin as a salvage therapy for treating urinary tract infections due to multidrug-resistant Escherichia coli.
    Nordmann P; Sadek M; Poirel L; Chakraborty T
    Eur J Clin Microbiol Infect Dis; 2022 Apr; 41(4):689-690. PubMed ID: 35118568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.